Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

This study is part of a bigger project for characterization of COVID-19 disease making use of genomes severely affected patients and 200 long COVID patients. We aim to discover not only any genetic differences between health, COVID-19 and Long COVID patients but also test their risk stratification according to already published polygenic risk scores (PRS). Quality control and concordance metrics were carried out with an Illumina and MGI 30x coverage test genome to validate our variant imputation pipeline.